• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in p...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Golf and Wellness: Enjoy Your Health in Full Swing
On June 11, 2016, over 3,000 properties in 83 countries will celebrate Global Wellness Day with the objective to touch the hearts and minds of 250 million people. Thousands of wellness activities will be organized, free of charge, by day spas and salons, hotel spas, fitness clubs, yoga/Pilates studios, ballet companies and dance schools, town halls, even golf clubs. Millions of people will be given the opportunity to try new fun and healthy activities, experience new sensations as bodies are pleasantly invited to breathe consciously, stretch to one's heart content, walk the talk, hike to discover new horizons, pack a scrum...
Source: Healthy Living - The Huffington Post - April 7, 2016 Category: Consumer Health News Source Type: news